The concept of a “Still’s disease continuum” that encompasses both sJIA and AOSD is based on the many common clinical, genetic and laboratory features shared by both sJIA and AOSD.
Read Article
Dr. Petros Efthimiou is a board-certified specialist in Rheumatology and Internal Medicine and a Clinical Professor of Medicine & Rheumatology in New York City.
A summa cum laude graduate of the University of Ioannina Medical School in Greece, Dr. Efthimiou became a Research Scholar at Northwestern University College of Medicine in Chicago, Illinois. He then completed his Internal Medicine Residency at Brown University in Providence, Rhode Island, while his Rheumatology Fellowship took place at the Hospital for Special Surgery and New York Presbyterian/Cornell Campus.
Dr. Efthimiou has expertise in the treatment of autoimmune disorders including Rheumatoid Arthritis, Psoriatic arthritis, gout, osteoarthritis, myositis, SLE-lupus, Sjogren’s syndrome, Vasculitis, Pulmonary Hypertension, Scleroderma, Osteoporosis, Auto-inflammatory Syndromes and Adult Still’s Disease. Dr. Efthimiou has published extensively in peer-reviewed journals and medical textbooks and has served as Clinical Investigator in multiple, international, randomized controlled trials. He has served as an ad hoc reviewer and editorial board member in peer-reviewed rheumatology journals and is a frequently invited speaker in national and international medical conferences.
A 2011-22 “Castle Connolly” and “US News & World Report”, "Top Doctor" in Rheumatology, he was the 2021 recipient of the American College of Rheumatology (ACR) "Hero in Rheumatology" Award and named a 2014-22“Super Doctor” by the New York Times and “Best Doctor” by New York Magazine.